9 March 2016
3rd Discovering Chemistry Lecture Series: Magic, Folk Medicine and Modern Drug Discovery
Organised by:
SCI's Young Chemists' Panel
Imperial College London
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
Following on from the success of the 2011 "International Year of Chemistry" and the 2013 "Discovering Chemistry" public lecture series, the SCI Young Chemists' Panel is pleased to announce the "3rd Discovering Chemistry Lecture series" hosted at Universities around the country in 2016.
The lectures will be given by industrial and academic experts who will illustrate how chemistry impacts our everyday lives in Britain and worldwide. The series aims to highlight how diverse the field of chemistry is and to provide a brief introduction to a few of the wide range of applications and cutting-edge technologies which fall under the chemistry umbrella. Titles such as "Extreme Drug Discovery", "Global Warming - How can Green Chemistry Help" and "Magic, Folk Medicine, Drugs and Chemistry" are certain to attract interested parties at all venues.
Attendees
Target audience: Year 12 & 13 school students studying chemistry, although much of the material is suitable for year 11 students and students studying sciences other than chemistry.Programme
Day 1 - 9th March 2016
Event Schedule
- 18:00 - 19:15
- Lecture duration
Venue and Contact
SCI Members attending this meeting are able to claim CPD points.
Additional Info
The Lecture
This lecture will describe how molecules isolated from Nature have played a key role in many human activities from magic through to drugs. It will illustrate how chemistry and chemists have developed some of the modern medicines that society now depends on and which have enhanced life expectancy so spectacularly in the last 100 years.
The Speaker
Dr David Witty is Chemistry Director & Operations Manager at Convergence Pharmaceuticals. He has worked in a number of Pharmaceutical companies, including Reckitts and GlaxoSmithKline, and in 2010, together with former
GSK colleagues, launched a new small biopharm company, Convergence Pharmaceuticals, which is focused on designing and developing new safe effective treatments for pain.